We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Retrieve More Information From Limited DNA

Cancerous tissue
Credit: iStock

Using liquid biopsies to profile cell free DNA (cfDNA) in blood could transform how we manage cancer, allowing for early detection and identification of residual disease and subtype. However, a standard blood draw only yields an average of 10 ng of cfDNA, of which DNA derived from the tumor is a small minority.

Novel sequencing technology can simultaneously derive genetic and epigenetic data in one read from a single DNA molecule.

This poster highlights how this technology can provide accurate detection of genetic variants and variant-associated methylation in colorectal cancer samples.

Download this poster to discover how to:

  • Obtain multi-modal information from liquid biopsies
  • Differentiate between healthy tissue and stage IV colorectal cancer 
  • Generate full methylome and genetic information at high accuracy in one workflow

Download the Poster for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.